Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Swedish lab offers hope on genital herpes vaccine

Share this article

10:33 CET+01:00
Researchers in Gothenburg have developed a promising new vaccine against genital herpes, with successful tests on mice offering hope of an STD-free future for millions, Gothenburg daily Göteborgs-Posten reports.

The vaccine, which uses a protein produced by the type 2 herpes virus together with a substance which stimulates the immune system, has been developed by researchers at the Sahlgrenska Academy in Gothenburg.

The research team vaccinated a sample of mice and were able to trace the infection - the first time this has been achieved with the herpes virus. The study found that somewhere between the mucous membrane and the spinal ganglion the infection lost its virility.

"We found the genome of the virus in the spinal cord, but no viable virus particles. We do not know where on the path from the mucous membrane to the nerve cell that it has lost its ability to cause disease," said Staffan Görander at the Sahlgrenska Academy to the newspaper.

It is hoped that further research will enable the new vaccine to provide protection against the most common form of genital herpes which is caused by the herpes simplex virus, with type 2 being the most common.

Around 500 million people are infected with genital herpes, which is transferred sexually and substantially increases the risk of being infected with HIV. There is currently no vaccine against the disease.

Get notified about breaking news on The Local

Share this article

Become a Member or sign-in to leave a comment.
Advertisement

From our sponsors

Teachers and students are lifelong learners at this Stockholm school

At Stockholm International School (SIS) is isn't just the students who are valued, challenged and prepared for the future. Teachers are also nurtured, with an intensive programme of professional development throughout the academic year.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement